Children’s Minnesota’s pharmacy residency program offers opportunities for first year residents. The first year program is designed to provide residents with a wide variety of clinical and professional experiences in pediatrics.
About the PGY1 pharmacy practice residency
The PGY1 pharmacy practice residency is designed to provide the first-year resident with a wide variety of clinical and professional experiences in pediatrics. Residents will complete required rotations and have approximately three months to complete elective learning experiences in areas of their interest.
The purpose of our ASHP-accredited PGY1 residency program is to provide experience and knowledge which foster the development of skills to fulfill the challenges of evolving roles in pharmacy practice. Residents completing the pharmacy practice residency program at Children’s are able to:
- Manage and improve the medication-use process
- Exercise leadership and practice management skills
- Demonstrate project management skills
- Provide medication and practice-related education/training
- Utilize medical informatics
- Participate in the management of medical emergencies
- Demonstrate additional competencies that contribute to working successfully in the health care environment
Upon completion of this residency program, residency graduates are prepared to successfully fulfill the requirements of a clinical staff pharmacist working with pediatric patients in a clinical setting.
Orientation/training
PGY1 Pharmacy Practice Residency
Residents will be oriented to the department during the first week of the residency. This will consist of an overview of Children’s Minnesota, the pharmacy department, introduction to department procedures and opportunities to discuss work responsibilities with various department members. The majority of training will occur during the first 5-6 weeks of the residency. It is expected that by the end of this time the resident will be competent to work on line shifts as a decentralized pharmacist at Children’s Minnesota. Residents may have the option to begin their orientation prior to July 1. Depending on when the resident begins their training, this could free up additional time for elective rotations later in the year.
Residency learning experiences
Individualized residency plan
We plan the learning experiences for the residency during the initial weeks of the residency year. The resident will complete a Resident Assessment and Plan for Training. Using this information, the resident’s primary preceptor will develop an individualized residency plan for the resident. Both the resident and the primary preceptor will agree to specific learning experiences.
Required learning experiences
The pharmacy practice residency program consists of required and elective learning experiences. The required learning experiences and their duration include:
PGY1 Pharmacy Practice Resident
- Orientation/training (5-6 weeks)
- Practice management (4 weeks followed by a longitudinal learning experience)
- Pediatric medicine (6 weeks)
- Pediatric intensive care (6 weeks)
- Neonatal intensive care (6 weeks)
- Staffing (Longitudinal learning experience)
- Residency project (Longitudinal learning experience)
- Teaching certificate (Longitudinal learning experience)
Elective learning experiences
The PGY1 pharmacy practice residents will have approximately 24 weeks for choosing elective learning experiences from either of Children’s Minnesota hospital campuses to meet their interests. In the past, residents have chosen to pursue elective learning experiences in areas including (but not limited to): cardiovascular intensive care, inpatient/outpatient hematology, inpatient/outpatient oncology, medication therapy management, emergency medicine, pharmacogenomics, antibiotic stewardship, toxicology, cystic fibrosis and endocrinology. The resident may also choose to repeat a required rotation at either campus. It must be noted that the maximum amount of time the resident can spend in the same clinical area is four months. Off-site learning experiences outside Children’s Minnesota may also be available for the resident.
Evaluations
Evaluation of the resident’s performance is vital to the resident’s development and will consist of (at least) the following evaluations.
Summative evaluations
Summative evaluations are completed by the preceptor at the conclusion of the resident’s learning experience and quarterly during longitudinal learning experiences. Summative evaluations are designed to evaluate the resident’s performance on the goals and objectives assigned to their learning experiences.
Formative evaluations
Formative evaluations are related to specific events and tasks. It is precise feedback given at a specific moment in time after observing the resident’s activity. Formative feedback is usually given verbally by the preceptor. Formative evaluations may be completed as often as deemed necessary by the preceptor.
Self-evaluations
Residents conduct self-evaluation of their work on an ongoing basis. The preceptor will prepare a program of self-evaluation for the learning experience and discuss it with the resident.
Preceptor and learning experience evaluation
Upon completion of the learning experience, the resident shall complete the Preceptor and Learning Experience Evaluation form to provide feedback for the preceptor.
Quarterly evaluations
Residents’ progress towards accomplishing their residency goals will be assessed quarterly using the Quarterly Summary of Residency Goals form. This will help focus efforts towards the goals that the resident has not made significant progress in achieving.
Department Meetings
Pharmacy leadership meeting
The Pharmacy Leadership Meeting is an informational meeting intended to keep management and clinical staffs current with department projects and up to date with recent developments in our department.
Pharmacy and Therapeutic Committee (P&T)
The residents are appointed to the Pharmacy and Therapeutics Committee as non-voting members. Each PGY1 resident will write at least two new drug reviews and present this information to the committee for formulary inclusion or exclusion. The residents’ medication use evaluations (MUE) will also be approved and reviewed by the Pharmacy and Therapeutics Committee.
Resident/preceptor meetings
Residents and preceptors from all programs will meet at least monthly to discuss current issues involving the residents and the respective residency program.
Clinical Pharmacy Practice Council (CPPC)
PGY1 pharmacy practice residents will attend the monthly CPPC meeting to discuss clinical issues affecting the department and care of patients at Children’s Minnesota.
Pharmacogenomics Oversight Committee (POC)
The POC meets every other month throughout the year. These are currently virtual meetings due to COVID-19 restrictions.
Genetics all-staff meetings
Genetics staff meetings are held regularly on the Minneapolis campus (currently virtual due to COVID restrictions) to communicate information to department staff.
Institutional Review Board (IRB)
Children’s Minnesota Institutional Review Board meets twice monthly.
Professional Meetings
National meetings
The department will pay for travel, lodging and meeting registration for one national meeting. The PGY1 pediatric pharmacy residents typically attend the Pediatric Pharmacy Association (PPA) annual meeting in late April and present the results of their residency project at the meeting.
Local professional meetings
Residents are strongly encouraged to attend local professional conferences that focus on current issues in pharmacotherapy. These would include the MSHP annual and mid-year meetings.
Presentations/teaching experiences
The resident will be scheduled to provide four case presentations that meet requirements to qualify as continued pharmacy education (CPE) credit with the Accreditation Council for Pharmacy Education (ACPE). The topic of these presentations will be related to a current learning experience and will be presented via network link to both of Children’s Minnesota hospital campuses. Preceptors of clinical rotations may also request the resident to present a case presentation or journal club at the end of their rotation. Residents should discuss with their preceptor the expectations for case presentations and journal clubs at the start of the rotation.
The PGY1 pharmacy practice residents also provide didactic coursework for pharmacy students at the Minnesota College of Pharmacy.
Teaching certificate
PGY1 pediatric pharmacy residents will complete and earn a teaching certificate during their residency year. The certificate is modeled on recommendations published by the American College of Clinical Pharmacy (ACCP) and includes large group didactic instruction, small group discussion and precepting.
Residency project
Each resident completes a research or major project as part of their residency training. Each resident will work with their preceptor in the selection of their project. The PGY1 pharmacy practice residents will present the results of this project at the Annual PPA Meeting in spring. Assistance in research project design and statistics is provided by Children’s Minnesota Research Sponsored Programs.
Adverse Drug Report Review
The PGY1 pharmacy practice residents will be responsible for maintaining the adverse drug report log.
Medication Use Evaluation (MUE)
Each PGY1 pharmacy practice resident will be responsible for developing, performing and presenting a MUE project during their residency. The results will be presented at the Pharmacy and Therapeutics committee and/or the medical division committee.
Resident trips
Each resident class is encouraged to tour different hospitals and pharmacy departments during the year. The purpose of these activities is to see alternative pharmacy systems and gain additional depth in knowledge and understanding in the provision of pharmacy services.
Resident salary and benefits
Residents receive salary and benefits for residency activities through Children’s Minnesota. The stipend is competitive. Dental and health insurance is provided in the benefits package offered by Children’s Minnesota.
Residents will have 30 days of paid time off (PTO) during the residency year. Residents will deduct compensation time, education time, sick time, etc., from their PTO account. The resident will need to notify their primary preceptor and staffing coordinator in advance regarding vacation requests.
Staffing responsibilities
PGY1 pharmacy practice residents will be scheduled to work every other weekend throughout the residency. In St. Paul, residents work five out of 12 weekends due to an occasional 12-hour shift. Each resident can expect to work either the Christmas or New Year’s holiday and additional holidays consistent with staffing patterns for the department.
Program preceptors
- Jessica Benshoof, PharmD, BCPS, BCPPS (Neonatal Intensive Care)
- Joan Erickson, BSPharm (Pediatric Intensive Care)
- Amy Gisslen, PharmD (Medication Safety)
- David Gregornik, BA, BS, PharmD (Pharmacogenomics)
- David Hoff, PharmD, BCPPS, FCCP, FPPA (Director of Clinical Pharmacy Services)
- Jill Johnson, PharmD, BCPPS (Staffing)
- Izzy Lawson, PharmD (Neonatal Intensive Care)
- Jennifer Lissick, PharmD, BCPS (Hemophilia Treatment Center)
- Polina Lipnik, PharmD, BCPPS (Cardiovascular Critical Care)
- Teresa Mansur, PharmD, BCPPS (Inpatient Oncology)
- Kim Maxa, PharmD, MBA, BCOP (Ambulatory Oncology)
- Katie Meyers, PharmD, BCPPS (Neonatal Intensive Care)
- Jen Miller, MA (Senior Clinical Analyst)
- Julie Most, PharmD, MBA (Senior Director of Pharmacy)
- Kati Munson, PharmD, BCPPS (General Pediatrics)
- Julie Palmquist, BSPharm, BCPPS (Pediatric Intensive Care)
- Monica Premsukh, PharmD (Staffing)
- Emily Price, PharmD, BCPPS (Emergency Medicine)
- Mike Raschka, PharmD, BCPPS (Clinical Pharmacy Coordinator; PGY1 Residency Program Director)
- Samuel Roiko, PhD
- Lisa Stay, PharmD, BCPPS (General Pediatrics)
PGY1 Pharmacy Residency requirements for completion:
- 80% of evaluated goals must be achieved by the end of the year;
- Medication Use Evaluation with results presented at P&T Committee or division-level meeting;
- At least 2 new drug reviews/class reviews for the P&T Committee;
- At least 2 system/department policy revisions;
- Present at least 4 Continuing Pharmacy Education (CPE) Presentations;
- Present results of a residency project at a national or regional conference;
- Completed manuscript describing your research project written according to guidelines for publication set forth by AJHP or other journal.
PGY1 pharmacy residents
Annika Cook
Annika Cook is originally from Hudson, Wisconsin, where she moved in 5th grade after living in York, Pennsylvania. She received her Doctor of Pharmacy from Drake University in Des Moines, Iowa.
Annika’s practice interests include neonatal intensive care and anything pediatrics at this point. She is excited about the opportunity to explore different inpatient and outpatient specialties throughout her residency year. Upon completion of her PGY1, Annika hopes to find a position that allows her to practice as a pediatric clinical pharmacist in the inpatient setting. She also aspires to become a preceptor and mentor for pharmacy students, as she is passionate about teaching and would like to incorporate academia into a clinical role.
Outside of pharmacy, Annika loves to spend much of her time with her niece, family, friends and two dogs. She also likes to try out different workouts/sports (most recently tennis) and go on long walks, particularly around the Stillwater bridge loop.
Megan Grierson
Meagan Grierson is originally from Dayton, Ohio. She received her Doctor of Pharmacy from Ohio Northern University.
Meagan’s current practice interests include critical care and emergency medicine. Upon completion of her PGY1, Meagan plans on practicing as a clinical pharmacist in the inpatient setting.
Outside of pharmacy, she enjoys baking, reading and spending time outdoors. She looks forward to exploring the numerous parks and trails in Minnesota.
Olivia Ratgen
Olivia Ratgen is originally from Hastings, Minnesota. She received both her Bachelor of Science in Psychology and Doctor of Pharmacy from the University of Minnesota Twin Cities.
Olivia’s practice interests include pediatric critical care and emergency medicine. Upon completion of her PGY1, Olivia plans on practicing as a clinical pharmacist in a pediatric emergency medicine setting.
Outside of pharmacy, Olivia loves spending time with her two dogs, husband, family and friends, as well as traveling, trying new restaurants and doing CrossFit.
- Hold a Doctor of Pharmacy degree from ACPE accredited college of pharmacy
- Be eligible for pharmacist licensure in the State of Minnesota (Minnesota Board of Pharmacy)
- Participate in the ASHP Resident Match Program
- Are a U.S. citizen or permanent resident (green card) or have a current F1 student visa
- Application
- Children’s Minnesota supplemental PGY1 Application
- Curriculum vitae
- Letters of reference from three individuals
- College of pharmacy transcripts
Q: How many residents do you have?
A: Children’s Minnesota currently accepts three PGY1 residents. Two of the PGY1 residents have offices and complete their staffing commitments on the Minneapolis campus. One PGY1 resident has an office and completes their staffing on the St. Paul campus. Note that for the PGY1 residency, each campus has a separate match number.
Q: When are applications due?
A: Applications for the PGY1 pharmacy practice residency need to be uploaded to the PhORCAS website by December 30. See the application tab for information on the application process.
Q: What happens after I submit my application?
A: Children’s Minnesota residency preceptors will review all applications and will notify applicants of their status. Some applicants may be placed on an alternate list if the number of candidates exceeds the number of interview slots.
Q: How is the program designed?
A: Each program is structured to provide you with an initial orientation/training module. During the orientation/training period, the PGY1 residents will work with their advisor to develop an individualized schedule that includes all required rotations, along with approximately 24 weeks of elective rotations, based on each resident’s interests. The full list of these rotations can be located under the “Program Overview” tab.
Q: What experiences are required?
A: Listed under the “Program Overview” tab, the required experiences are listed for each specific residency program.
Q: What electives are available?
A: In the past, residents have chosen to pursue elective learning experiences in areas including (but not limited to): cardiovascular intensive care, inpatient/outpatient hematology, inpatient/outpatient oncology, medication therapy management, emergency medicine, pharmacogenomics, antibiotic stewardship, toxicology, cystic fibrosis and endocrinology. Off-site learning experiences outside Children’s may also be available for the resident.
Q: How are residents evaluated?
A: In the past, residents have chosen to pursue elective learning experiences in areas including (but not limited to): cardiovascular intensive care, inpatient/outpatient hematology, inpatient/outpatient oncology, epilepsy, medication therapy management, emergency medicine, clinical pharmacogenomics, antibiotic stewardship, toxicology, cystic fibrosis and endocrinology. Off-site learning experiences outside Children’s Minnesota may also be available for the resident.
Q: Is research required?
A: Yes, each resident is required to complete a research or major project as part of their residency training. These projects may be individualized to the resident’s specific interests.
Q: What teaching opportunities exist?
A: Residents will be scheduled to provide quarterly continued pharmacy education (CPE) presentations to the pharmacy staff. The topic of these presentations will be related to their current learning experience. In addition to these presentations, the resident may give case presentations at the conclusion of clinical rotations and have the option of providing didactic coursework for pharmacy students at the Minnesota College of Pharmacy. Residents may also assist with the preceptorship of pharmacy students on rotation at Children’s Minnesota throughout the year and have the opportunity to earn a teaching certificate as a longitudinal experience.
Q: Is staffing required?
A: The PGY1 pharmacy practice residents in Minneapolis will be scheduled to staff every other weekend throughout the residency. In St. Paul, the resident will work five out of 12 weekends due to an occasional 12-hour shift. Each PGY1 resident can expect to work either the Christmas or New Year’s holiday and additional holidays consistent with staffing patterns for the department.
Q: Must I be licensed?
A: All pharmacy residents are required to be licensed in the State of Minnesota within 90 days of starting the residency.
Q: How do I get licensed?
A: Information regarding pharmacy licensure in Minnesota can be found at the Board of Pharmacy’s website.
Q: What is the salary?
A: Residents receive their salary and benefits for residency activities through Children’s Minnesota. The stipend varies by role. Dental and health insurance is provided in the benefits package offered by Children’s.
Q: How much vacation time is there?
A: Residents will receive 30 days of paid time off during the residency year. Residents will deduct compensation time, education time, sick time, etc., from their PTO account. The resident will need to notify their primary preceptor and staffing coordinator in advance regarding vacation requests.
Questions?
For questions about the PGY1 Pharmacy Practice Residency or to schedule a meeting with the RPD, a preceptor or a current resident: